These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 26614249

  • 21. Mesalamine (5-ASA) for the prevention of recurrent diverticulitis.
    Carter F, Alsayb M, Marshall JK, Yuan Y.
    Cochrane Database Syst Rev; 2017 Oct 03; 10(10):CD009839. PubMed ID: 28973845
    [Abstract] [Full Text] [Related]

  • 22. [Modern indications on the medical treatment of symptomatic diverticular disease].
    Ierfone N, Di Fulvio A, Pontone S, Terzakis P, Martino G, Pontone P.
    G Chir; 2006 Mar 03; 27(3):93-6. PubMed ID: 16681868
    [Abstract] [Full Text] [Related]

  • 23. Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials.
    Iannone A, Ruospo M, Wong G, Barone M, Principi M, Di Leo A, Strippoli GFM.
    Can J Gastroenterol Hepatol; 2018 Mar 03; 2018():5437135. PubMed ID: 30320044
    [Abstract] [Full Text] [Related]

  • 24. Effectiveness of different therapeutic strategies in preventing diverticulitis recurrence.
    Tursi A, Elisei W, Giorgetti GM, Inchingolo CD, Nenna R, Picchio M, Maiorano M, Penna A, Lecca PG, Brandimarte G.
    Eur Rev Med Pharmacol Sci; 2013 Feb 03; 17(3):342-8. PubMed ID: 23426537
    [Abstract] [Full Text] [Related]

  • 25. New medical strategies for the management of acute diverticulitis.
    Tursi A.
    Expert Rev Gastroenterol Hepatol; 2015 Feb 03; 9(10):1293-304. PubMed ID: 26289102
    [Abstract] [Full Text] [Related]

  • 26. Management of diverticulosis: what's new?
    Elisei W, Brandimarte G, Tursi A.
    Minerva Med; 2017 Oct 03; 108(5):448-463. PubMed ID: 28466633
    [Abstract] [Full Text] [Related]

  • 27. A randomized controlled study of mesalamine after acute diverticulitis: results of the DIVA trial.
    Stollman N, Magowan S, Shanahan F, Quigley EM, DIVA Investigator Group.
    J Clin Gastroenterol; 2013 Aug 03; 47(7):621-9. PubMed ID: 23426454
    [Abstract] [Full Text] [Related]

  • 28. Advances in the management of colonic diverticulitis.
    Tursi A.
    CMAJ; 2012 Sep 18; 184(13):1470-6. PubMed ID: 22927512
    [No Abstract] [Full Text] [Related]

  • 29. Preventing diverticulitis recurrence by selecting the right therapy for a complex disease.
    Tursi A, Danese S.
    Gastroenterology; 2014 Oct 18; 147(4):733-6. PubMed ID: 25167986
    [No Abstract] [Full Text] [Related]

  • 30. Acute diverticulitis of the colon--current medical therapeutic management.
    Tursi A.
    Expert Opin Pharmacother; 2004 Jan 18; 5(1):55-9. PubMed ID: 14680435
    [Abstract] [Full Text] [Related]

  • 31. Colonic diverticular disease. Treatment and prevention.
    Gargallo Puyuelo CJ, Sopeña F, Lanas Arbeloa A.
    Gastroenterol Hepatol; 2015 Dec 18; 38(10):590-9. PubMed ID: 25979437
    [Abstract] [Full Text] [Related]

  • 32. [Follow-up observation of intestinal Behçet disease treated with salazosulfapyridine and mesalazine for 8 years and 9 months].
    Kitauchi S, Ohata H, Kuroda R, Hirose M, Sakaguchi A, Nishi S, Nishioka S.
    Nihon Shokakibyo Gakkai Zasshi; 1998 Feb 18; 95(2):140-4. PubMed ID: 9513566
    [No Abstract] [Full Text] [Related]

  • 33. Management of diverticulitis: results of a survey among gastroenterologists and surgeons.
    de Korte N, Klarenbeek BR, Kuyvenhoven JP, Roumen RM, Cuesta MA, Stockmann HB.
    Colorectal Dis; 2011 Dec 18; 13(12):e411-7. PubMed ID: 21819518
    [Abstract] [Full Text] [Related]

  • 34. Mesalazine for diverticular disease of the colon--a new role for an old drug.
    Tursi A.
    Expert Opin Pharmacother; 2005 Jan 18; 6(1):69-74. PubMed ID: 15709884
    [Abstract] [Full Text] [Related]

  • 35. Mesalamine Does Not Help Prevent Recurrent Acute Colonic Diverticulitis: Meta-Analysis of Randomized, Placebo-Controlled Trials.
    Khan MA, Ali B, Lee WM, Howden CW.
    Am J Gastroenterol; 2016 Apr 18; 111(4):579-81. PubMed ID: 27125717
    [No Abstract] [Full Text] [Related]

  • 36. Treatment of Diverticular Disease With Aminosalicylates: The Evidence.
    Barbara G, Cremon C, Barbaro MR, Bellacosa L, Stanghellini V.
    J Clin Gastroenterol; 2016 Oct 18; 50 Suppl 1():S60-3. PubMed ID: 27622369
    [Abstract] [Full Text] [Related]

  • 37. Reply: To PMID 25167986.
    Raskin JB, Kamm MA, Streck P.
    Gastroenterology; 2015 Apr 18; 148(4):856-7. PubMed ID: 25726740
    [No Abstract] [Full Text] [Related]

  • 38. Probiotic therapy with E. coli for ulcerative colitis: take the good with the bad.
    Faubion WA, Sandborn WJ.
    Gastroenterology; 2000 Mar 18; 118(3):630-1. PubMed ID: 10702217
    [No Abstract] [Full Text] [Related]

  • 39. The metabolism of mesalamine and its possible use in colonic diverticulitis as an anti-inflammatory agent.
    Cohen HD, Das KM.
    J Clin Gastroenterol; 2006 Aug 18; 40 Suppl 3():S150-4. PubMed ID: 16885699
    [Abstract] [Full Text] [Related]

  • 40. Irritable bowel syndrome and colonic diverticular disease: overlapping symptoms and overlapping therapeutic approaches.
    Alamo RZ, Quigley EMM.
    Curr Opin Gastroenterol; 2019 Jan 18; 35(1):27-33. PubMed ID: 30407258
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.